Your browser doesn't support javascript.
loading
Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP).
Menon, Usha; Weller, David; Falborg, Alina Zalounina; Jensen, Henry; Butler, John; Barisic, Andriana; Knudsen, Anne Kari; Bergin, Rebecca J; Brewster, David H; Cairnduff, Victoria; Fourkala, Evangelia Ourania; Gavin, Anna T; Grunfeld, Eva; Harland, Elizabeth; Kalsi, Jatinderpal; Law, Rebecca-Jane; Lin, Yulan; Turner, Donna; Neal, Richard D; White, Victoria; Harrison, Samantha; Reguilon, Irene; Lynch, Charlotte; Vedsted, Peter.
Afiliação
  • Menon U; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London, UK. u.menon@ucl.ac.uk.
  • Weller D; Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.
  • Falborg AZ; Research Unit for General Practice, Aarhus, Denmark.
  • Jensen H; Research Unit for General Practice, Aarhus, Denmark.
  • Butler J; The Royal Marsden NHS Foundation Trust, London, UK.
  • Barisic A; Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada.
  • Knudsen AK; European Palliative Care Research Centre (PRC), Department of Oncology, Oslo, Norway.
  • Bergin RJ; University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Brewster DH; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia.
  • Cairnduff V; Department of General Practice, University of Melbourne, Melbourne, VIC, Australia.
  • Fourkala EO; Centre for Population Health Sciences, University of Edinburgh, Edinburgh, UK.
  • Gavin AT; Scottish Cancer Registry, Edinburgh, UK.
  • Grunfeld E; Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK.
  • Harland E; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Kalsi J; Northern Ireland Cancer Registry, Queen's University Belfast, Belfast, UK.
  • Law RJ; Health Services Research Program, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.
  • Lin Y; Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, Canada.
  • Turner D; Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women's Health, University College London, London, UK.
  • Neal RD; North Wales Centre for Primary Care Research, Bangor University, Wrexham, UK.
  • White V; European Palliative Care Research Centre (PRC), Department of Oncology, Oslo, Norway.
  • Harrison S; Population Oncology, Cancer Care Manitoba, Winnipeg, Canada.
  • Reguilon I; Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
  • Lynch C; School of Psychology Deakin University, Geelong, VIC, Australia.
  • Vedsted P; Centre for Behavioral Research in Cancer, Cancer Council Victoria, Melbourne, VIC, Australia.
Br J Cancer ; 127(5): 844-854, 2022 09.
Article em En | MEDLINE | ID: mdl-35618787
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Benchmarking Tipo de estudo: Diagnostic_studies / Guideline / Qualitative_research Limite: Female / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Benchmarking Tipo de estudo: Diagnostic_studies / Guideline / Qualitative_research Limite: Female / Humans Idioma: En Revista: Br J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido